Industry – Page 4
-
NewsCalibr announces license agreement with Gilead to develop long-acting HIV antiviral agent
Long-acting combination HIV regimens have the potential to transform the future of coordinated HIV clinical care
-
NewsIndustry collaboration funds development of RNA drugs against dengue fever virus
University team use patented nuclear magnetic resonance (NMR)-based screening method to identify small molecules that specifically bind to the viruses’ highly conserved RNA structures and interrupt the viral infection cycle.
-
NewsSimplified formulation of oral cholera vaccine, licensed by Korean regulatory agency
Euvichol-S, a simplified formulation of oral cholera vaccine, has been licensed by Korean regulatory agency, and is expected to alleviate global cholera vaccine shortages.
-
NewsSoil microbiome yields revolutionary new biofungicide
The Boyce Thompson Institute (BTI), a leader in plant science research, has announced that Ascribe Bioscience has partnered with Nutrien Ag Solutions to commercialize two crop protection products containing biofungicide Phytalix®.
-
NewsDenovAI uses artificial intelligence to discover therapeutic antibodies
Kashif Sadiq has founded a start-up – DenovAI – for broader, faster and cheaper antibody discovery using advanced machine learning and computational biophysics.
-
News€20 million EIB venture debt financing to support microbiome research and development
The EIB has signed €20 million in venture debt financing with Belgian microbiome health company The Akkermansia Company to accelerate the R&D and commercial activities around the Akkermansia muciniphila bacterium.
-
![Pioneer Awards - Emmanuel Ladent, Carbios, and Jacques Playe, L'Oreal[88]](https://d3rmrttq0bsnxi.cloudfront.net/Pictures/100x67/7/4/8/4748_pioneerawardsemmanuelladentcarbiosandjacquesplayeloreal88_710603.jpg)
NewsCarbios and L’Oréal win Pioneer Award for world’s first enzymatically recycled cosmetic bottle
The Solar Impulse Foundation has recognised Carbios’ breakthrough innovation and its adoption in 2021 by L’Oréal with the world’s first fully enzymatically recycled plastic cosmetic bottle.
-
NewsIridescentBio bringing virtual high-throughput assays to antibody R&D
IridescentBio is a new techbio start-up that’s bringing creative chemistry, physics know-how and methods to the Biopharma R&D world. The team of four are building computational models in the cloud to provide forecasting superpowers for lab-based research and development of antibody therapeutics. IridescentBio’s modelling framework is already ...
-
NewsSaudi Public Health Authority and BGI Genomics sign MoU to advance public health
BGI Genomics has signed a Memorandum of Understanding (MoU) with the Saudi Public Health Authority (PHA) to inject new impetus into the cause of public health in Saudi Arabia.
-
NewsNew typhoid conjugate vaccine Bio-TCV® approved in Indonesia
Bio Farma’s Bio-TCV® typhoid conjugate vaccine (TCV) has been licensed in Indonesia following marketing approval from Badan Pengawas Obat dan Makanan (BPOM), the national regulatory authority.
-
NewsNew dawn in the fight against TB
UNITE4TB, the largest public-private collaboration in tuberculosis drug development, announces the start of clinical trials.
-
NewsOndine Biomedical Inc announces study showing photodisinfection reduces resistant bacteria by >99.9%
Canadian life sciences company Ondine Biomedical Inc. has presented new research showing that Steriwave® photodisinfection reduced antibiotic-resistant bacteria by more than 99.9%.
-
NewsBactiVac funded to develop bacterial vaccines in global fight against AMR
The UK government has awarded the University of Birmingham-hosted Bacterial Vaccines Network (BactiVac) £1.4 million in funding to accelerate the development of bacterial vaccines as part of the fight against antimicrobial resistance (AMR).
-
NewsNew test for sepsis could save lives in emergency departments
Interdisciplinary research has found that a new blood test for sepsis could save lives and money.
-
NewsSRI spins off AI-powered drug discovery platform Synfini, Inc
SRI International has announced it is spinning off Synfini, a biosciences platform that accelerates the process by which pharmaceutical and other companies can design, synthesize, and bring to market molecules for drug development.
-
NewsValneva announces new IXIARO® supply contract with the US government
Specialty vaccine company Valneva SE has announced the signing of a new $32 million contract with the United States Department of Defense for the supply of its Japanese encephalitis vaccine, IXIARO®.
-
NewsTeselaGen Biotechnology renews partnership with Joint BioEnergy Institute
TeselaGen Biotechnology has announced that it is extending its relationship with Joint BioEnergy Institute (JBEI) through 2027 via a new multi-year contract.
-
NewsNICER than CRISPR: new gene editor reduces unintended mutations
Researchers led by Osaka University develop a new gene modification technique known as NICER that significantly reduces off-target mutations in DNA.
-
NewsResearchers awarded €1.2 million to commercialise cultivated meat
Companies have received €1.2 million in additional funding from EIT Food to develop innovative products to reduce the cost of producing cultivated meat within the next two years.
-
NewsE coli bacteria engineered to generate electricity from wastewater
Scientists have reported a groundbreaking achievement in bioelectronics, advancing the capabilities of common E. coli bacteria to generate electricity.